Cargando…

Stringent doxycycline-dependent control of gene activities using an episomal one-vector system

Conditional expression systems are of pivotal importance for the dissection of complex biological phenomena. Here, we describe a novel EBV-derived episomally replicating plasmid (pRTS-1) that carries all the elements for conditional expression of a gene of interest via Tet regulation. The vector is...

Descripción completa

Detalles Bibliográficos
Autores principales: Bornkamm, Georg W., Berens, Christian, Kuklik-Roos, Conny, Bechet, Jean-Marie, Laux, Gerhard, Bachl, Jürgen, Korndoerfer, Martin, Schlee, Martin, Hölzel, Michael, Malamoussi, Anastassia, Chapman, Rob D., Nimmerjahn, Falk, Mautner, Josef, Hillen, Wolfgang, Bujard, Hermann, Feuillard, Jean
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1201338/
https://www.ncbi.nlm.nih.gov/pubmed/16147984
http://dx.doi.org/10.1093/nar/gni137
_version_ 1782124904805564416
author Bornkamm, Georg W.
Berens, Christian
Kuklik-Roos, Conny
Bechet, Jean-Marie
Laux, Gerhard
Bachl, Jürgen
Korndoerfer, Martin
Schlee, Martin
Hölzel, Michael
Malamoussi, Anastassia
Chapman, Rob D.
Nimmerjahn, Falk
Mautner, Josef
Hillen, Wolfgang
Bujard, Hermann
Feuillard, Jean
author_facet Bornkamm, Georg W.
Berens, Christian
Kuklik-Roos, Conny
Bechet, Jean-Marie
Laux, Gerhard
Bachl, Jürgen
Korndoerfer, Martin
Schlee, Martin
Hölzel, Michael
Malamoussi, Anastassia
Chapman, Rob D.
Nimmerjahn, Falk
Mautner, Josef
Hillen, Wolfgang
Bujard, Hermann
Feuillard, Jean
author_sort Bornkamm, Georg W.
collection PubMed
description Conditional expression systems are of pivotal importance for the dissection of complex biological phenomena. Here, we describe a novel EBV-derived episomally replicating plasmid (pRTS-1) that carries all the elements for conditional expression of a gene of interest via Tet regulation. The vector is characterized by (i) low background activity, (ii) high inducibility in the presence of doxycycline (Dox) and (iii) graded response to increasing concentrations of the inducer. The chicken beta actin promoter and an element of the murine immunoglobin heavy chain intron enhancer drive constitutive expression of a bicistronic expression cassette that encodes the highly Dox-sensitive reverse tetracycline controlled transactivator rtTA2(S)-M2 and a Tet repressor-KRAB fusion protein (tTS(KRAB)) (silencer) placed downstream of an internal ribosomal entry site. The gene of interest is expressed from the bidirectional promoter P(tet)bi-1 that allows simultaneous expression of two genes, of which one may be used as surrogate marker for the expression of the gene of interest. Tight down regulation is achieved through binding of the silencer tTS(KRAB) to P(tet)bi-1 in the absence of Dox. Addition of Dox releases repression and via binding of rtTA2(S)-M2 activates P(tet)bi-1.
format Text
id pubmed-1201338
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-12013382005-09-15 Stringent doxycycline-dependent control of gene activities using an episomal one-vector system Bornkamm, Georg W. Berens, Christian Kuklik-Roos, Conny Bechet, Jean-Marie Laux, Gerhard Bachl, Jürgen Korndoerfer, Martin Schlee, Martin Hölzel, Michael Malamoussi, Anastassia Chapman, Rob D. Nimmerjahn, Falk Mautner, Josef Hillen, Wolfgang Bujard, Hermann Feuillard, Jean Nucleic Acids Res Methods Online Conditional expression systems are of pivotal importance for the dissection of complex biological phenomena. Here, we describe a novel EBV-derived episomally replicating plasmid (pRTS-1) that carries all the elements for conditional expression of a gene of interest via Tet regulation. The vector is characterized by (i) low background activity, (ii) high inducibility in the presence of doxycycline (Dox) and (iii) graded response to increasing concentrations of the inducer. The chicken beta actin promoter and an element of the murine immunoglobin heavy chain intron enhancer drive constitutive expression of a bicistronic expression cassette that encodes the highly Dox-sensitive reverse tetracycline controlled transactivator rtTA2(S)-M2 and a Tet repressor-KRAB fusion protein (tTS(KRAB)) (silencer) placed downstream of an internal ribosomal entry site. The gene of interest is expressed from the bidirectional promoter P(tet)bi-1 that allows simultaneous expression of two genes, of which one may be used as surrogate marker for the expression of the gene of interest. Tight down regulation is achieved through binding of the silencer tTS(KRAB) to P(tet)bi-1 in the absence of Dox. Addition of Dox releases repression and via binding of rtTA2(S)-M2 activates P(tet)bi-1. Oxford University Press 2005 2005-09-07 /pmc/articles/PMC1201338/ /pubmed/16147984 http://dx.doi.org/10.1093/nar/gni137 Text en © The Author 2005. Published by Oxford University Press. All rights reserved
spellingShingle Methods Online
Bornkamm, Georg W.
Berens, Christian
Kuklik-Roos, Conny
Bechet, Jean-Marie
Laux, Gerhard
Bachl, Jürgen
Korndoerfer, Martin
Schlee, Martin
Hölzel, Michael
Malamoussi, Anastassia
Chapman, Rob D.
Nimmerjahn, Falk
Mautner, Josef
Hillen, Wolfgang
Bujard, Hermann
Feuillard, Jean
Stringent doxycycline-dependent control of gene activities using an episomal one-vector system
title Stringent doxycycline-dependent control of gene activities using an episomal one-vector system
title_full Stringent doxycycline-dependent control of gene activities using an episomal one-vector system
title_fullStr Stringent doxycycline-dependent control of gene activities using an episomal one-vector system
title_full_unstemmed Stringent doxycycline-dependent control of gene activities using an episomal one-vector system
title_short Stringent doxycycline-dependent control of gene activities using an episomal one-vector system
title_sort stringent doxycycline-dependent control of gene activities using an episomal one-vector system
topic Methods Online
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1201338/
https://www.ncbi.nlm.nih.gov/pubmed/16147984
http://dx.doi.org/10.1093/nar/gni137
work_keys_str_mv AT bornkammgeorgw stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem
AT berenschristian stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem
AT kuklikroosconny stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem
AT bechetjeanmarie stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem
AT lauxgerhard stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem
AT bachljurgen stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem
AT korndoerfermartin stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem
AT schleemartin stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem
AT holzelmichael stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem
AT malamoussianastassia stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem
AT chapmanrobd stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem
AT nimmerjahnfalk stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem
AT mautnerjosef stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem
AT hillenwolfgang stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem
AT bujardhermann stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem
AT feuillardjean stringentdoxycyclinedependentcontrolofgeneactivitiesusinganepisomalonevectorsystem